On May 30, executive personnel were reshuffled.
Yuhan Corp. has appointed Kim Yeol-hong, head of the R&D headquarters (president), as the general manager of R&D.
On May 30, Yuhan Corporation (CEO Wook-Je Cho) reorganized some organizations and reshuffled executives to improve the efficiency of the R&D organization and secure growth engines.
The central research institute and clinical medicine division under the existing R&D headquarters were upgraded to the business division level, and the central research institute, clinical medicine headquarters, and R&BD headquarters were reorganized under the direct control of Kim Yeol-hong, R&D president.
According to the reorganization, executive director Se-woong Oh, head of the central research institute, Hyo-young Lim, head of the clinical medicine division, and Jae-chun Yoo, executive director of the pharmaceutical business division, were promoted to vice president respectively.
Newly appointed Vice President Youngmi Lee, who was recruited as the head of the R&BD Division, received a Ph.D. from Seoul National University Graduate School of Pharmacy, was a research professor in the Department of Biotechnology at Yonsei University, and a Research Fellow at the Dana-Farber Cancer Institute at Harvard Medical School. , has been in charge of the R&BD organization.
Copyright © News The Voice Healthcare Unauthorized reproduction and redistribution prohibited
2023-05-31 05:43:52
#Kim #Yeolhong #appointed #general #manager #Yuhan #Corp
